DARE compared with OBAI: revenue, margins and what each company keeps, and the suppliers and customers both name

DAREDare Bioscience, Inc.

Mkt capRevenueRevenue

OBAIOur Bond, Inc.

Mkt capRevenueRevenue

Compare

DAREDare Bioscience, Inc.

OBAIOur Bond, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

DAREDare Bioscience, Inc.

0.63▲+0.96%

Mkt cap$9.5MRevenue$187,546Q2 FY26

OBAIOur Bond, Inc.

1.68▼−5.62%

Regular sessionNov 6 '26

Mkt cap$2.2MRevenue$2MQ2 FY26

Compare

Regular sessionNov 6 '26

DAREDare Bioscience, Inc.

OBAIOur Bond, Inc.

0.63▲+0.96%

Price

1.68▼−5.62%

$9.5M

Mkt cap

$2.2M

Q2 FY26$187,546

Revenue

$2MQ2 FY26

DARE0.63▲+0.96%vsOBAI1.68▼−5.62%Regular sessionNov 6 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DARE: latest quarter is a loss; flow not drawable. OBAI: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DARE 5

OGNOrganoncustomer

—Bravado Pharmaceuticalsunlistedsupplier

—Catalent JNPunlistedsupplier

—Medvantxunlistedsupplier

1 more · DARE chain ›

Shared 0

No shared counterparties.

Only OBAI 1

—largest customerunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

DARE, solidOBAI, dashed